Physician

Neil F Notaroberto, M.D.

According to 2025 Medicare claims, Neil Notaroberto, M.D. (NPI: 1730150822) practices ophthalmology in the Slidell-Mandeville-Covington, LA market, with the plurality of this provider's patient population coming from St. Tammany, LA. This provider's primary affiliated billing organization is 4 YOUR EYES, LLC (NPI: 1437329034; TIN: 721416649) and primary practice location at 70471-2968.

Notaroberto's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 958 traditional Medicare patients, billed 10,454 HCPCS/CPT codes, and received $661,499 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 2,972 prescription claims across 738 beneficiaries totaling $1,418,135 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 24 records totaling $470. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $218,155 to $1,418,135. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$331K$661K2015 Medicare payment: $481,804 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $469,814 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $451,607 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $443,498 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $458,283 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $481,967 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $528,720 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $547,353 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $596,362 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $661,499 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159675,751$481,804
20169155,278$469,814
20178955,755$451,607
20188986,248$443,498
20199886,247$458,283
20208995,412$481,967
20219325,112$528,720
20229584,956$547,353
20239357,694$596,362
202495810,454$661,499

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$709K$1.4M2015 Drug cost: $218,155 (USD; Tot_Drug_Cst)2016 Drug cost: $232,077 (USD; Tot_Drug_Cst)2017 Drug cost: $245,075 (USD; Tot_Drug_Cst)2018 Drug cost: $275,726 (USD; Tot_Drug_Cst)2019 Drug cost: $366,370 (USD; Tot_Drug_Cst)2020 Drug cost: $291,895 (USD; Tot_Drug_Cst)2021 Drug cost: $261,359 (USD; Tot_Drug_Cst)2022 Drug cost: $259,278 (USD; Tot_Drug_Cst)2023 Drug cost: $631,566 (USD; Tot_Drug_Cst)2024 Drug cost: $1,418,135 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157453,178$218,155
20167613,173$232,077
20177253,124$245,075
20187473,149$275,726
20198723,705$366,370
20206442,593$291,895
20216202,316$261,359
20227052,646$259,278
20237392,878$631,566
20247382,972$1,418,135

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
66984Removal of cataract with insertion of prosthetic lens143224$382
92014Established patient complete exam of visual system7561,361$79
92012Established patient problem focused exam of visual system125137$59
92134Imaging of retina220487$26
92250Photography of the retina582727$24

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine381,800$35,849
LumiganBimatoprost843,854$34,678
IlevroNepafenac692,145$25,776
VyzultaLatanoprostene Bunod261,145$13,635
LatanoprostLatanoprost1,01070,992$12,827

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.24$470Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Neil F. Notaroberto, M.D.?

Tedicare shows public-source Medicare data for Neil F. Notaroberto, M.D. (NPI 1730150822), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Neil F. Notaroberto, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Neil F. Notaroberto, M.D.?

Neil F. Notaroberto, M.D. is linked to 4 YOUR EYES, LLC (billing NPI 1437329034) in the available physician profile data.

Does Neil F. Notaroberto, M.D. have Open Payments data?

Neil F. Notaroberto, M.D. has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.